Literature DB >> 15930262

Tumor suppressor VDUP1 increases p27(kip1) stability by inhibiting JAB1.

Jun-Ho Jeon1, Kee-Nyung Lee, Chae Young Hwang, Ki-Sun Kwon, Kwan-Hee You, Inpyo Choi.   

Abstract

Vitamin D3 up-regulated protein 1 (VDUP1) is a stress-response gene that is up-regulated by 1,25(OH)2D3 in many cells. It has been reported that VDUP1 expression is reduced in many tumor cells and the enforced expression of VDUP1 inhibits cell proliferation by arresting cell cycle progression. Here, we found that VDUP1-/- fibroblast cells proliferated more rapidly compared with wild-type cells with reduced expression of p27(kip1), a cyclin-dependent kinase inhibitor. JAB1 is known to interact with p27(kip1) and to decrease the stability of p27(kip1). VDUP1 interacted with JAB1 and restored JAB1-induced suppression of p27(kip1) stability. In this process, VDUP1 blocked the JAB1-mediated translocation of p27(kip1) from the nucleus to the cytoplasm. In addition, VDUP1 inhibited JAB1-mediated activator protein-1 activation and cell proliferation. Taken together, these results indicate that VDUP1 is a novel factor of p27(kip1) stability via regulating JAB1.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15930262     DOI: 10.1158/0008-5472.CAN-04-2271

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  58 in total

1.  A global genomic view on LNX siRNA-mediated cell cycle arrest.

Authors:  Dan Zheng; Shaohua Gu; Yao Li; Chaoneng Ji; Yi Xie; Yumin Mao
Journal:  Mol Biol Rep       Date:  2010-11-21       Impact factor: 2.316

2.  Thioredoxin-independent regulation of metabolism by the alpha-arrestin proteins.

Authors:  Parth Patwari; William A Chutkow; Kiersten Cummings; Valerie L R M Verstraeten; Jan Lammerding; Eric R Schreiter; Richard T Lee
Journal:  J Biol Chem       Date:  2009-07-15       Impact factor: 5.157

3.  Effects of vitamin D3 stimulation of thioredoxin-interacting protein in hepatocellular carcinoma.

Authors:  James P Hamilton; James J Potter; Lahari Koganti; Stephen J Meltzer; Esteban Mezey
Journal:  Hepatol Res       Date:  2014-03-25       Impact factor: 4.288

4.  Ras Suppresses TXNIP Expression by Restricting Ribosome Translocation.

Authors:  Zhizhou Ye; Donald E Ayer
Journal:  Mol Cell Biol       Date:  2018-09-28       Impact factor: 4.272

5.  Thioredoxin-interacting protein mediates high glucose-induced reactive oxygen species generation by mitochondria and the NADPH oxidase, Nox4, in mesangial cells.

Authors:  Anu Shah; Ling Xia; Howard Goldberg; Ken W Lee; Susan E Quaggin; I George Fantus
Journal:  J Biol Chem       Date:  2013-01-17       Impact factor: 5.157

6.  A novel role of myosin VI in human prostate cancer.

Authors:  Thomas A Dunn; Shenglin Chen; Dennis A Faith; Jessica L Hicks; Elizabeth A Platz; Yidong Chen; Charles M Ewing; Jurga Sauvageot; William B Isaacs; Angelo M De Marzo; Jun Luo
Journal:  Am J Pathol       Date:  2006-11       Impact factor: 4.307

7.  AMPK-dependent degradation of TXNIP upon energy stress leads to enhanced glucose uptake via GLUT1.

Authors:  Ning Wu; Bin Zheng; Adam Shaywitz; Yossi Dagon; Christine Tower; Gary Bellinger; Che-Hung Shen; Jennifer Wen; John Asara; Timothy E McGraw; Barbara B Kahn; Lewis C Cantley
Journal:  Mol Cell       Date:  2013-02-28       Impact factor: 17.970

8.  Restoration of cytoskeletal and membrane tethering defects but not defects in membrane trafficking in the intestinal brush border of mice lacking both myosin Ia and myosin VI.

Authors:  Peter S Hegan; Dmitri V Kravtsov; Christina Caputo; Marie E Egan; Nadia A Ameen; Mark S Mooseker
Journal:  Cytoskeleton (Hoboken)       Date:  2015-09-16

9.  Tandem ChoRE and CCAAT motifs and associated factors regulate Txnip expression in response to glucose or adenosine-containing molecules.

Authors:  Fa-Xing Yu; Yan Luo
Journal:  PLoS One       Date:  2009-12-22       Impact factor: 3.240

10.  JAB1/CSN5: a new player in cell cycle control and cancer.

Authors:  Terry J Shackleford; Francois X Claret
Journal:  Cell Div       Date:  2010-10-18       Impact factor: 5.130

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.